InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
2.020
-0.100 (-4.72%)
Sep 15, 2026, 4:00 PM EDT - Market closed
InflaRx Employees
InflaRx had 65 employees as of December 31, 2025. The number of employees decreased by 9 or -12.16% compared to the previous year.
Employees
65
Change (1Y)
-9
Growth (1Y)
-12.16%
Revenue / Employee
n/a
Profits / Employee
-$688,021
Market Cap
297.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 74 | 12 | 18.97% |
| Dec 31, 2023 | 62 | 18 | 40.41% |
| Dec 31, 2022 | 44 | -12 | -20.75% |
| Dec 31, 2021 | 56 | 9 | 18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| Lyell Immunopharma | 161 |
| Zentalis Pharmaceuticals | 106 |
| SAB Biotherapeutics | 86 |
| Agenus | 81 |
| Upstream Bio | 75 |
| Vicore Pharma Holding AB | 46 |
IFRX News
- 1 day ago - InflaRx Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 1 day ago - InflaRx initiated with a Buy at Needham - TheFly
- 6 days ago - InflaRx Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 26 days ago - InflaRx Announces Participation in September Investor Conferences - GlobeNewsWire
- 5 weeks ago - InflaRx Earnings release: Q2 2026 - Filings
- 5 weeks ago - InflaRx files $250M mixed securities shelf - TheFly
- 5 weeks ago - InflaRx Registration statement: Registration filing - Filings
- 5 weeks ago - InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones - GlobeNewsWire